EAISX | VTISX | EAISX / VTISX | |
Total Expense Ratio | 0.78 | 0.05 | 1,660% |
Annual Report Gross Expense Ratio | 0.88 | 0.05 | 1,872% |
Fund Existence | 16 years | 9 years | - |
Gain YTD | 25.512 | 26.176 | 97% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 3000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 287M | 546B | 0% |
Annual Yield % from dividends | 2.65 | 2.79 | 95% |
Returns for 1 year | 15.65 | 18.05 | 87% |
Returns for 3 years | 58.99 | 62.57 | 94% |
Returns for 5 years | 40.15 | 45.09 | 89% |
Returns for 10 years | 66.29 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FINSX | 50.97 | 0.06 | +0.12% |
Fidelity Advisor New Insights I | |||
FIRCX | 10.04 | 0.01 | +0.10% |
Fidelity Advisor Intl Real Estate C | |||
NBHAX | 15.14 | 0.01 | +0.07% |
Neuberger Berman Equity Income A | |||
BIPSX | 29.24 | -0.05 | -0.17% |
ProFunds Biotechnology UltraSector Svc | |||
GEMCX | 24.24 | -0.05 | -0.21% |
Goldman Sachs Emerging Markets Eq C |